Previous Article | Next Article ![]()
Journal of Clinical Microbiology, April 2006, p. 1536-1539, Vol. 44, No. 4
0095-1137/06/$08.00+0 doi:10.1128/JCM.44.4.1536-1539.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Microbiology Division, Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287-7093
Received 30 August 2005/ Returned for modification 15 October 2005/ Accepted 14 January 2006
Candida lusitaniae is an opportunistic yeast pathogen that has the ability to develop resistance to amphotericin B (AmB). The mechanism(s) for this resistance is not well understood, although there are data supporting mutations in sterol pathways and other data supporting phenotypic switching (PS). The goal of this study was to determine whether C. lusitaniae has a PS system and to characterize any phenotypes, including any changes in AmB MICs. When 104 CFU of an AmB-resistant (MIC of 16 to 32 µg/ml) clinical strain was plated on yeast-peptone-dextrose (YPD) agar with 1 mM CuSO4, three colony colors were observed: light brown (LB) >> dark brown (DB) > white (W), similar to the result for Candida glabrata. Switching did occur with high AmB resistance (MIC of 256 µg/ml) being associated with W, whereas LB and DB colonies had MICs of 2 to 8 µg/ml and 2 to 16 µg/ml, respectively. Filamentation (pseudohyphae) was associated with DB colonies. All phenotypes occurred spontaneously with greater frequency (
102 to 104) than spontaneous mutations, and all phenotypes were reversible, fulfilling the two PS criteria. High AmB MICs were always associated with W colonies but not with all W colonies. Detection of PS on YPD-CuSO4 is also similar to that in Candida glabrata, and we hypothesize that this is due to similarities in metallothionein gene expression. Phenotypic switching represents a key strategy in C. lusitaniae that confers a selective advantage during environmental challenges, including the ability to switch to AmB resistance.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|